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INTRODUCTION
Pain can be defined as an unpleasant sensory and emotional experience associated with actual and potential tissue damage, or described in terms of such damage. [1, 2] An experience of poorly managed pain resulting from the surgical removal of any tooth is a validated pain model. The pain in this model is both predictable and consistent, beginning 1-3 h after surgery and ranging in intensity from moderate to severe. [3] The postoperative period of such condition is characterized by pain, trismus and inflammation as the most frequent complications. [4] Such type of pain has also both physiological and psychological components and such experience can lead patients to avoid or postpone treatment, as well as make them more difficult to treat and less likely to comply with prescribed regimens.
An ideal drug substance for administration after the surgical removal of the tooth should alleviate pain, reduce inflammation and trismus, facilitate healing and cause no undesirable side effects. [4] To compensate this type of dental pain, monotherapy or combination therapies are prescribed by many clinicians. Pharmacological management of such pain involves the administration of medications which include: Opioid analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), local anesthetics, glucocorticoids and alpha 2 agonists.
The efficacy of a single dose of paracetamol (500 mg) alone or in combination in relieving this pain compared to commonly use NSAIDs, such as ibuprofen, diclofenac sodium, flurbiprofen, ketoprofen, and naproxen has been demonstrated in numerous studies in which paracetamol served as the active control. [3, 6] Among NSAIDs, diclofenac sodium is a time-tested commonly used NSAID used in painful conditions including acute postoperative pain. [3, 4] As far as a concern with side effects; it results in gastrointestinal (GI) toxicity and peptic ulcer as the inhibitory action on prostaglandin (PG) synthesis by inhibition of cyclooxygenase (COX)-1 and COX-2 enzymes. [5, 7] Pathology induced by tooth extraction is very common and is attributable to a singular series of embryologic and anatomical circumstances. [4] Several studies had postulated that these types of drugs with or without combination, when compared to each other after extraction of the tooth as an effective pain model, significant effect with adverse effect was seen. [3] However, pain is subjective phenomenon and it can vary from patient to patient and it has been postulated that the success ratio of analgesia depends on the influence of patient sex, their anxiety level upon postoperative pain levels, though it seems logical that the increased anxiety can have influence on GI secretions that effectively may have some influence upon the postoperative course and effect of analgesia.
The purpose of the present study is to compare the analgesic efficacy, tolerability and safety of diclofenac sodium with paracetamol and paracetamol alone in the management of pain following tooth extraction.
MATERIALS AND METHODS
The study was carried out according to the protocol approved by the Independent Ethics Committee in accordance with the declaration of Helsinki and CDSCO "Good clinical practice" guidelines. The present study was designed as an open label, parallel group, randomized trial, in which 50 patients were randomly allocated to two different groups. They are selected as per inclusion/exclusion criteria after obtaining written informed consent. Patients aged between 16 and 35 years undergoing tooth extraction under local anesthesia and who has the ability to complete a 10 cm visual analog scale were only included in the study. Patients with known hypersensitivity to study drugs, patients with history of peptic ulcers or GI bleeding, patients with severe kidney/liver disease, patients who were taking angiotensin-converting enzyme inhibitor; potassium-sparing diuretics, aspirin, warfarin or other anticoagulants were excluded from study. Study participants were divided into two groups -Group A and Group B as per computer generated randomization sheet.
The extraction procedure was carried out using routine and standardized procedure under local anesthesia using 2% lignocaine and 1:1,00,000 adrenaline. Treatment with the antibiotic and analgesic corresponding to each group was started when the patient's pain reached moderate to severe intensity (Visual Analogue Scales [VAS] 5-8) after surgical extraction. All the enrolled patients were given amoxicillin 500 mg every 8 h for 4 days. Group A were given diclofenac 50 mg + paracetamol 500 mg every 12 h for 4 days and Group B were given paracetamol 500 mg every 6 h for 4 days. If the patient had no relief in pain within 2 h rescue analgesic (paracetamol 500 mg orally) was given to a maximum of 4 doses per day.
The primary efficacy parameters, total degree of pain relief (TOTDPR) (0-4 scale, none as 0, a little as 1, moderate as 2, a lot as 3; complete as 4), were analyzed from baseline to 30 min, 1, 2, 4, 6, 8, 24, 48 h and at end of 4 th day of extraction. Secondary measures of efficacy were included i.e. Average pain intensity (API) difference time; administration of rescue medication and its number. A number of adverse events and number of patients with adverse drug reactions (ADRs) were also recorded with Naranjo's scale to evaluate drug safety. All efficacy endpoints were derived from direct, patient-reported entries in the pain assessment case report forms completed up to 4 th day postoperatively. Drug efficacy and tolerability were also analyzed by Patients' and physician's global assessment score in terms of poor, satisfactory, good and excellent and statistically measured.
Statistical methods
The sample size was estimated for TOTDPR and API over whole drug administration period and assessed every time using a 0-10 VAS, to demonstrate the superiority of both groups. A sample size in each group was calculated to provide 90% power to detect a difference between groups as a power calculation. All continuous variables, TOTDPR, API, and ADR were analyzed and presented as mean (standard deviation), and categorical variables are presents as count and percentage. Student's t-test was used to compare between-group means while the comparison between categorical qualitative data was done using a Chi-squared test. The significance level was considered at P < 0.05. The collected data were entered and statistically analyzed using SPSS version 16. The possibility of ADR was also noted.
RESULTS
The study was conducted in 50 patients. The age range of both groups was between 16 and 35 years, among them 16 were males and 34 were females. 26 patients were enrolled in Group A (9 male and 17 female) with mean age was 27.73 ± 6.30 and 24 patients were enrolled in Group B (7 male and 17 female) with mean age was 27.46 ± 5.82. There was no significant difference between two groups [ Table 1 ].
Average baseline pain intensity (API) in Group A was 6.76 ± 1.45 while in Group B; it was 6.00 ± 1.29. After administration of the study medications, pain intensity was decreased significantly at all the time points in both groups [P < 0.01, Table 2 ]. Significantly higher differences in pain intensity were achieved with Group A compared to Group B at 2, 4, 6, 8 and 24 h after extraction [P < 0.05, Table 3 ]. TOTDPR for Group A was comparable to that of Group B at different time points [P > 0.05, Table 4 ]. 92% of patients in Group A achieved maximum pain intensity difference within 30 min as compared to 87.5% in Group B.
No rescue medication was required in Group A during the entire study. While in Group B, nine patients (37.5%) required rescue medication during the study period. ADR in each group after 4 th day was evaluated by Naranjo's scale and statistically analyzed. Out of 26 patients of Group A, 7 patients (14%) had possible ADRs between 1 and 4, which were in the form of nausea, feeling of vomiting only. Two patients (4%) had been reported with mild heartburn in Group A with probable ADR score of 5. No ADR was found in Group B, which was significant (P > 0.05) between two groups [ Table 5 ]. No any serious ADR found during study course in both groups.
Drug efficacy of patient's global assessment score for Group A (n = 26) was good in 14 patients (53.8%) and excellent in 11 patients (42.3%), while for Group B (n = 24), 2 (8.3%) were reported with poor score, 5 (20.8%) with satisfactory, 8 (33.3%) with good and 9 (37.5%) had an excellent score. Drug efficacy of physician's global assessment score for Group A was excellent in 17 patients (70.8%) and rest 9 patients (34.6%) had a good score. In Group B, out of 24, 12 patients (50%) had excellent response, 9 (37.5%) had good score, 2 (8.3%) had satisfactory and 1 (4.1%) had poor score.
Drug tolerability of patient's global assessment score for Group A was excellent and good in 19 (73.07%) and 6 (23%) patients respectively. While for Group B 10 out of 24 patients (41.6%) had excellent scores. 
DISCUSSION
Various pain models have been designed for applications in the context of clinical trials in various fields of medicines and surgeries. The present study was performed after extraction of the tooth because acute tissue trauma causes inflammation that increases the responsiveness of local nociceptors, as well as antiinflammatory drug therapy. Thus, the extraction of teeth is a clinically validated, reliable model for acute pain and evaluating the efficacy of analgesics. [3, 4] In day to day dental practice, varieties of NSAIDs and other pain relieving medications are advised, and varieties of responses, even in same drugs were obtained from patients to patients. However, this type of study requires the prior induction of sufficient background of pain, a low placebo effect, a homogenous study population, and good patient cooperation. Extraction pain meet many of this conditions. [5] The development of new pain management strategies equips dental clinicians with additional treatment options that can provide more effective pain relief.
Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment. NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit the biosynthesis of PGs at the level of the COX enzyme pathways. Structurally, most NSAIDs are organic acids with low pK values that lend themselves to their accumulation at sites of inflammation, areas that often exhibit lower pH than uninvolved sites. Most often, there is a direct relationship between low pK and short half-life, but there are exceptions -such as nabumetone, which is nonacidic. Most traditional NSAIDs inhibit both COX isoforms and they are grouped according to their chemical structures, plasma half-life, and COX-1 versus COX-2-selectivity. This COX-isozyme selectivity is likely to be a critically important factor in determining relative GI and the cardiovascular risk that should also be considered in addition to other pharmacologic properties for each NSAID. [8] Any trauma or systemic inflammation gives rise to metabolic and behavioral changes, largely mediated by pro-inflammatory cytokines and prostaglandin E2 (PGE 2 ) production at the blood-brain barrier. [9, 10] Diclofenac sodium and other NSAIDs differ widely in their chemical class but share the property of blocking the production of PGs (PGs). [11] Extraction of teeth produces a fair amount of tissue injury to the surrounding tissue leading to the release of arachidonic acid, which is converted into PG by cyclooxygenase. [2] The widely prescribed NSAID, diclofenac is an aminophenylacetic acid that inhibits PG biosynthesis to produce analgesic, antipyretic, and anti-inflammatory activity secondary to its nonselective inhibition of the cyclooxygenase (COX) enzymes, COX-1 and COX-2. Various studies have shown that diclofenac exerts a dose-dependent analgesic effect, based on the inhibition of PG. [11] In this context, diclofenac sodium is a well-known NSAID that has been used for many years in the medical field since it offers a good combination of efficacy, inflammation control, and better patient tolerance. At present, most clinical trials are comparing the analgesic efficacy of different drugs with reference medication paracetamol, due to its analgesic capacity, good tolerability, and near total lack of complications or side effects when administered. Our study we have compared diclofenac + paracetamol with paracetamol. [4] As far as a concern with adverse effects of diclofenac NSAID, ultrastructural damage to the gastric surface epithelium occurs within minutes after ingestion of NSAIDs and gross endoscopically debatable hemorrhages and erosions in the gastroduodenal epithelium occurs within hours. A review of the short-term used NSAIDs concluded that there was no evidence of increased risk of severe GIT complications of perioperative (<1 week) NSAIDs treatment. However, patient with active or previous GIT ulcer should be excluded from the study. [2, 12] Furthermore, PGs has little influence on renal blood flow or glomerular filtration rate in normal individuals. It may have major shifts in fluid compartments, as well as activation of the neurohumoral stress response, lead to reduced sodium and potassium excretion with the mean rise in serum creatinine. Whereas, paracetamol exerts weaker inhibition of peripheral PG synthesis than NSAIDs, but it does produce effects on sodium and water excretion comparable to diclofenac but not on renal blood flow or glomerular filtration rate. [12] An overdose of paracetamol can occasionally lead to irreversible liver injury that can be lethal. Hepatotoxicity has been reported in chronic alcoholics after ingestion of a therapeutic dose of paracetamol. [12] However; many of the adverse effects of NSAIDs are also related to inhibition of PG production, making their use problematic in some patient populations. [8] For the clinician, understanding the biology of PG as it relates to gastrointestinal, renal, and cardiovascular physiology and the pharmacologic properties of specific NSAIDs is key to using these drugs safely. Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients. In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option. For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential. [8] Some NSAIDs lack inhibition of platelet function, which is the operational definition of COX-2-selective NSAIDs. [8] Diclofenac sodium has more action on COX-2 as compared to COX-1. Thus, it is sparing antiplatelet action. [13] Inhibition of COX-2 by NSAIDs blocks PGE 2 production at sites of inflammation or other forms of tissue damage, while inhibition of COX-1 in certain other tissues most importantly, platelets and the gastroduodenal mucosa can lead to common adverse effects of NSAIDs such as bleeding and GI ulceration. [8] In our study, there was no any adverse effect like bleeding.
In the present study, an important concern is the pain evaluation period along with monitoring of ADRs. In effect, with the introduction of long-acting analgesics, prolonged observation periods have become necessary in the context of single-dose studies. This study includes how the patients use a daily dosing regimen over the 4 days period as a function of the change in the intensity of their pain over the time. The rate and way of medication use on the subsequent days of the study and the low number of tablets used by these patients in Group A suggests, 3-4 days is a sufficient duration for a multiple-dose dental pain study. The efficacy variables considered are pain intensity and relief, the estimation of total analgesia, the peak analgesic effect, and the start and duration of analgesic action. [4] This is in agreement with previous studies that the intensity of pain after extraction follows a patient's gender, variable time course, patient's pain perception, degree of tissue damage, presence of infection or not, but in general pain may peak 6-8 h after extraction due to anesthetic effect, then fading in intensity. [3] In the present study, pain intensity was assessed using pictorial and numerical ten points VAS at different time interval. It is designed to present to the patient a rating scale with minimum constraints. It is simple, quick to score and avoids imprecise descriptive terms. VAS scores during treatment and baseline show a Gaussian distribution allowing for the use of parametric statistical analysis. This scale is widely applied in studies on dental pain. [4] The results indicated that each of measures of pain intensity is adequately valid.
After administration of the study medications, API was decreased significantly at all the time points in both the groups (P < 0.01), but it was better achieved with Group A while compared to Group B at 2, 4, 6, 8 and 24 h. Further, there was no need of rescue medication for Group A whereas 37.5% of patients of Group B required rescue medication during the study period. [3] [4] [5] In the present study, the combined drug regimen NSAID with acetaminophen were better. As fixed dose combination of diclofenac 50 mg + paracetamol 500 mg requires twice a day administration as compared with paracetamol 500 mg four times a day lead to better drug efficacy and tolerability and patient compliance in our pilot study. It implies that the advantage of combining analgesics delivers comparable analgesia at lower and tolerable doses. Combining drugs with a differing time of onset, duration, site and mode of action can greatly enhance their capacity to minimize pain with better tolerance and recovery time. [3] In head -to head clinical trial of paracetamol versus diclofenac with paracetamol combined regimen, there was significantly greater improvement found in pain scores for patients in the diclofenac group. This finding was magnified in those patients with more severe pain at baseline. [8] According to various reviews and textbooks, recommended dose of diclofenac sodium is TID/BD. [13] The pilot study showed better response with BD dose. Furthermore, this drug was given in combination with paracetamol and hence may improve and provide the long effect of analgesia.
Most of the monotherapeutic options for postoperative dental pain have limitations. Various studies reported delayed onset of analgesia effect of paracetamol. Acetaminophen is effective and safe for mild pain, but often is inadequate for more severe pain after dental surgery and has demonstrated a ceiling effect at a higher dosage. This can be explained from the fact that drug passage through the blood-brain barrier is concentration dependent and with an increase in the rate of concentration, onset of analgesia will be faster and longer. [9] In Group B, nine patients required rescue analgesia during the study period. However, Group A patients didn't require rescue analgesia, may be improved the analgesic effect of combined regimen even at low dosage. [3] This study had succeeded in demonstrating the analgesic efficacy of both drugs with acceptable incidence and severity of side effects. Number of ADRs were noted with Naranjo's scale. Among 50 patients, 7 (14%) in Group A patients were reported with possible ADR and 2 patients with probable ADR. No any serious ADR was found in both groups. In agreement with previous studies, we have detected highest no. of patients of ADRs in elder age, may be on multiple therapies. This implies that the pharmacologic properties, including chemical class, formulation, and drug half-life of individual drugs may be equally important in determining the properties of NSAIDs. In light of the widespread use of NSAIDs for common diseases, which are likely to increase in prevalence with the aging of the population, it is critically important to appreciate the potential adverse events associated with NSAIDs to use them safely in patients. [8] Furthermore, in elder patients multiple therapies need to be discouraged as these enhance the probability of ADRs, due to drug-drug interactions. [14] In present study, physician's and patient's global assessment scores were analyzed, which was more in favor of Group A. However, the incidence of adverse events, predominantly GI upset, was low with 8 patients of Group A while compared with Group B regimen, and no serious adverse events were reported. These tolerability results, although not unexpected in such a short-term study, confirm that the benefit: Risk ratio of administering low-dose NSAIDs after dental surgery is extremely favorable. Although chronic use of NSAIDs is associated with gastric erosion and the risk of gastric bleeding, especially in those with pre-existing peptic ulceration, the risk is considerably less for acute usage, such as that described in this study. [5] [6] [7] The present study was randomized open label type. The number of open-label extension studies being performed has increased enormously in recent years. If undertaken primarily to gather more patient-years of exposure to the new drug in order to understand and gain confidence in its safety profile, open-label extension studies can play a useful and legitimate role in drug development and therapeutics. However, this can only occur if the openlabel extension study is designed, executed, analyzed and reported competently. We still have to rely heavily on safety surveillance systems to determine benefits and drawbacks of the studied drug. [15] CONCLUSION Both groups of drugs were found to be effective. Paracetamol should be tried as the initial therapy in a patient with mild to moderate pain for reasons of safety and cost. However, in moderate to severe pain and or with evidence of profound inflammation patients should be moving to treatment with diclofenac with paracetamol combined drug regimen to provide more rapid and effective relief by keeping mind of their possible ADRs.
